Capital City Trust’s Eli Lilly LLY Stock Holding History

Capital City Trust’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.19M	Sell	1,290 -44	-3%	-$44.6K	0.27%	63
2025 Q4	$1.43M	Sell	1,334 -190	-12%	-$182K	0.32%	58
2025 Q3	$1.16M	Sell	1,524 -40	-3%	-$29.8K	0.28%	65
2025 Q2	$1.22M	Sell	1,564 -10	-0.6%	-$7.77K	0.32%	62
2025 Q1	$1.3M	Buy	1,574 +776	+97%	+$646K	0.36%	61
2024 Q4	$616K	Sell	798 -24	-3%	-$19.9K	0.15%	77
2024 Q3	$728K	Buy	822 +6	+0.7%	+$5.39K	0.18%	76
2024 Q2	$739K	Hold	816	–	–	0.2%	75
2024 Q1	$635K	Sell	816 -72	-8%	-$51.2K	0.18%	79
2023 Q4	$518K	Buy	888 +21	+2%	+$12.3K	0.15%	82
2023 Q3	$466K	Sell	867 -80	-8%	-$41.2K	0.15%	84
2023 Q2	$444K	Hold	947	–	–	0.14%	88
2023 Q1	$325K	Buy	947 +8	+0.9%	+$2.7K	0.1%	98
2022 Q4	$344K	Buy	939 +85	+10%	+$30.1K	0.11%	95
2022 Q3	$277K	Hold	854	–	–	0.1%	101
2022 Q2	$277K	Buy	+854	New	+$256K	0.09%	105
2013 Q3	–	Sell	-1,490	Closed	-$73K	–	156
2013 Q2	$73K	Buy	+1,490	New	+$81.1K	0.03%	109

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital City Trust's LLY Position: Q1 2026 in Review

Capital City Trust reduced its Eli Lilly (LLY) stake by 3.3% in Q1 2026, selling an estimated $44.6K and leaving 1,290 shares worth $1.19M. The position accounts for 0.27% of the portfolio, ranked #63.

Capital City Trust first reported a position in LLY in Q2 2013 and has held it in 17 quarters since. The position peaked at $1.43M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Capital City Trust held 1,290 shares of Eli Lilly worth $1.19M as of Q1 2026.
Capital City Trust sold 44 Eli Lilly shares in Q1 2026, an estimated $44.6K.
Eli Lilly made up 0.27% of Capital City Trust's portfolio in Q1 2026, its #63 holding.
Capital City Trust first reported a position in Eli Lilly in Q2 2013 and has held it in 17 quarters since.
Capital City Trust's Eli Lilly position peaked at $1.43M in Q4 2025.
4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Capital City Trust's 13F filing for Q1 2026, filed 1 May 2026.